These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33013244)

  • 1. Delayed
    Xu L; Shi Y; Wang Y; Zhou X; Huang G; Chen R; Liu J
    Contrast Media Mol Imaging; 2020; 2020():3216179. PubMed ID: 33013244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
    Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
    Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic Lymph Node Staging by Combined
    Pichler R; De Zordo T; Fritz J; Kroiss A; Aigner F; Heidegger I; Virgolini I; Horninger W; Uprimny C
    Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of early dynamic and delayed post-diuretic
    Sharma A; Mete UK; Sood A; Kakkar N; Gorla AK; Mittal BR
    Br J Radiol; 2017 Apr; 90(1072):20160787. PubMed ID: 28256904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diagnostic Value of FDG-PET/CT for Urachal Cancer.
    Stokkel LE; Stokkel MPM; Donswijk ML; Lahaye MJ; Bekers EM; van Rhijn BWG; Mertens LS
    Clin Genitourin Cancer; 2021 Oct; 19(5):373-380. PubMed ID: 33858788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Utility of
    Das JP; Vargas HA; Ghafoor S; Goh AC; Ulaner GA
    J Nucl Med; 2021 May; 62(5):643-647. PubMed ID: 32948680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed
    Yan H; Zhou X; Wang X; Li R; Shi Y; Xia Q; Wan L; Huang G; Liu J
    Radiology; 2019 Oct; 293(1):144-150. PubMed ID: 31407969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of dual-energy CT used as an add-on to 18F FDG PET/CT in the preoperative staging of resectable NSCLC with suspected single osteolytic metastases.
    Wu H; Dong S; Li X; Shi L; Shao D; Zhang Q; Chen M; Cao Y; Thant M; Huang X
    Lung Cancer; 2020 Feb; 140():80-86. PubMed ID: 31901595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting malignancy in patients with adrenal tumors using
    Vos EL; Grewal RK; Russo AE; Reidy-Lagunes D; Untch BR; Gavane SC; Boucai L; Geer E; Gopalan A; Chou JF; Capanu M; Strong VE
    J Surg Oncol; 2020 Dec; 122(8):1821-1826. PubMed ID: 32914407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of
    Girard A; Rouanne M; Taconet S; Radulescu C; Neuzillet Y; Girma A; Beaufrere A; Lebret T; Le Stanc E; Grellier JF
    Eur Radiol; 2019 Aug; 29(8):4286-4293. PubMed ID: 30666449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.
    Nayak B; Dogra PN; Naswa N; Kumar R
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):386-93. PubMed ID: 23179944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
    J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wang HC; Wang ZM; Wang YB; Chen XH; Cui LL
    Abdom Radiol (NY); 2017 May; 42(5):1415-1423. PubMed ID: 28028557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of
    Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
    Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G; Colletti PM; Rubello D; Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D
    Clin Nucl Med; 2018 Jun; 43(6):402-410. PubMed ID: 29485442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.